Ophthalmic Therapeutic Innovation
Ophthalmic Therapeutic Innovation
  • Home
  • About OTI
    • Mission
    • Vision
    • History
    • Contact Us
  • Glaucoma
  • Breakthrough Discovery
  • Pipeline
  • Team
  • Publications
  • News
  • More
    • Home
    • About OTI
      • Mission
      • Vision
      • History
      • Contact Us
    • Glaucoma
    • Breakthrough Discovery
    • Pipeline
    • Team
    • Publications
    • News
  • Home
  • About OTI
    • Mission
    • Vision
    • History
    • Contact Us
  • Glaucoma
  • Breakthrough Discovery
  • Pipeline
  • Team
  • Publications
  • News

Publications

Understanding the Biology in Current Cell and Gene Therapy for Treating Macular Diseases

 Guanting Qiu T (2023) . Macular Diseases - An Update. IntechOpen. 

 https://www.intechopen.com/online-first/1163128 

Trabodenoson on trabecular meshwork rejuvenation: a comprehensive review of clinical data

 Qiu TG. Expert Opin Investig Drugs. 2021 Mar;30(3):227-236. doi: 10.1080/13543784.2021.1873276. Epub 2021 Jan 21. PMID: 33405971. 

 https://www.tandfonline.com/doi/full/10.1080/13543784.2021.1873276 

Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells (MA09-hRPE) in

 Qiu TG. NPJ Regen Med. 2019 Aug 27;4:19. doi: 10.1038/s41536-019-0081-8. PMID: 31482011; PMCID: PMC6712006. 

 https://www.nature.com/articles/s41536-019-0081-8 

The Global Ophthalmology Meeting Presentations

OTI Presented at 2024 Ophthalmology -Future Forum: https://vimeo.com/1008380727

OTI Presented at 2023 Ophthalmology -Future Forum: https://vimeo.com/1008380727


Copyright © OTI 2025 -  All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept